Filter
430
Filtered Results: 430
Text search:
pharmacokinetics
Featured
Recommendations
54
New Publications
87
Language
Document type
No document type
230
Guidelines
95
Studies & Reports
64
Manuals
18
Training Material
8
Fact sheets
7
Strategic & Response Plan
6
Situation Updates
1
Online Courses
1
Countries / Regions
India
24
Ethiopia
11
Global
10
Kenya
8
Latin America and the Carribbean
8
South Africa
7
Russia
7
Africa
6
Western and Central Europe
6
Sierra Leone
5
Zimbabwe
5
Germany
5
Bangladesh
5
Uganda
5
Zambia
5
Ghana
4
Eastern Europe
4
Brazil
4
Namibia
4
Ukraine
3
Rwanda
3
Nigeria
3
Tanzania
3
South–East Asia Region
3
East and Southern Africa
3
Argentina
3
Liberia
3
Thailand
2
Cameroon
2
Cambodia
2
West and Central Africa
2
Paraguay
2
Eswatini/ Swaziland
2
Nepal
1
Lesotho
1
Australia
1
Syria
1
Burkina Faso
1
Philippines
1
Mozambique
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
North America
1
Denmark
1
Sudan
1
Angola
1
Botswana
1
South Sudan
1
Indonesia
1
Authors & Publishers
Publication Years
Category
Countries
119
Clinical Guidelines
101
Public Health
20
Women & Child Health
17
Capacity Building
4
Pharmacy & Technologies
3
Key Resources
2
Toolboxes
TB
69
HIV
54
AMR
37
Pharmacy
26
Mental Health
25
NTDs
23
COVID-19
17
Ebola & Marburg
12
NCDs
10
Refugee
6
Planetary Health
6
Rapid Response
5
Caregiver
5
Disability
3
Polio
2
Global Health Education
2
Natural Hazards
1
Conflict
1
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
Handout presentations in PDF for illustrating lectures
Accessed May 2014
A survival guide for clinicans.
3rd edition.
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked med...
NOVEMBER 2012
This document serves as an update to “Out of the Dark”, a report published by MSF in October 2011, highlighting the need to prioritise the long-neglected area of paediatric tuberculosis (TB). This update will outline the key improvements and setbacks—the ‘highlights’ and ‘...
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
The following checklist is a companion to Core Elements of Hospital Antibiotic Stewardship Programs. This checklist should be used to systematically assess key elements and actions to ensure optimal antibiotic prescribing and limit overuse and misuse of antibiotics in hospitals. CDC recommends that ...
The following checklist is a companion to Core Elements of Hospital Antibiotic Stewardship Programs. This checklist should be used to systematically assess key elements and actions to ensure optimal antibiotic prescribing and limit overuse and misuse of antibiotics in hospitals. CDC recommends that ...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri...
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
Afr J Tradit Complement Altern Med. (2016) 13(4):123-131
Out of 400 questionnaires distributed to the participants, 389 were returned with data acceptable for analysis. Ages of the participants ranged from 18 to 75 years (Mean=43 + 11.6). Out of the 272 (69.9%) participants who conceded that th...
Out of 400 questionnaires distributed to the participants, 389 were returned with data acceptable for analysis. Ages of the participants ranged from 18 to 75 years (Mean=43 + 11.6). Out of the 272 (69.9%) participants who conceded that th...
After completing this activity, pharmacists should be able to:
1. List populations for which the compounding of an oral liquid may be necessary
2. Outline necessary considerations that should be made by the pharmacist to ensure product stability
3. Describe methods used in the compounding of liqu...
PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16
